CTOs on the Move

Equipment Placement Svc

www.equipmentplacement.com

 
Equipment Placement Svc is a Streetman, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Bayer Pharmaceutical Manufacturing Services

Bayer Pharmaceutical Manufacturing Services is a Shawnee, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EyeWatch LIVE

EyeWatch Live is a company that provides a virtual nurse monitoring system that combines artificial intelligence (AI) with human intelligence (HI) to identify unwanted activity and prevent falls before they occur.

Sarepta

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.

Reverse Medical Corporation

Reverse Medical Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Irvine, CA. To find more information about Reverse Medical Corporation, please visit www.reversemed.com

Menlo Therapeutics

We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.